KEGG   DRUG: Revakinagene taroretcel
Entry
D13084                      Drug                                   
Name
Revakinagene taroretcel (USAN/INN);
Revakinagene taroretcel-lwey;
Encelto (TN)
Product
ENCELTO (Neurotech Pharmaceuticals)
Remark
Product: D13084<US>
Efficacy
Neurodegenerative diseases agent, Ophthalmic agent
  Type
Cellular therapy product
Comment
Cell-based gene therapy
Treatment of Macular telangiectasia type II
Target
CNTF [HSA:1270] [KO:K05420]
  Pathway
hsa04060  Cytokine-cytokine receptor interaction
hsa04630  JAK-STAT signaling pathway
Brite
Target-based classification of drugs [BR:br08310]
 Cytokines and receptors
  Cytokines
   CSF and other factors
    CNTF
     D13084  Revakinagene taroretcel (USAN/INN) <US>
New drug approvals in the USA [br08319.html]
 Cellular and gene therapy products
  D13084
New drug approvals in the USA, Europe and Japan [br08328.html]
 Approval dates by FDA, EMA and PMDA
  D13084
Other DBs
PubChem: 507530399
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system